Furthermore, studies have found that a lower CD4+/CD8+ ratio at diagnosis is linked to poor prognosis in patients with multiple myeloma and Waldenström’s macroglobulinemia (23, 24). This evidence concerns the gene CD4 and AL amyloidosis.